Article Cited by others


Metabolic effects of testosterone replacement therapy on hypogonadal men with type 2 diabetes mellitus: a systematic review and meta-analysis of randomized controlled trials

Cai Xiang, Tian Ye, Wu Tao, Cao Chen-Xi, Li Hong, Wang Kun-Jie

Year : 2014| Volume: 16| Issue : 1 | Page no: 146-152

   This article has been cited by
1 The Effects of Androgens on Cardiometabolic Syndrome: Current Therapeutic Concepts
Omer Faruk Kirlangic,Didem Yilmaz-Oral,Ecem Kaya-Sezginer,Gamze Toktanis,Aybuke Suveyda Tezgelen,Ekrem Sen,Armagan Khanam,Cetin Volkan Oztekin,Serap Gur
Sexual Medicine. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Androgen Therapy in Male Patients Suffering from Type 2 Diabetes: A Review of Benefits and Risks
Mortaza F. Hassanabad,Mohammad Fatehi
Current Diabetes Reviews. 2020; 16(3): 189
[Pubmed]  [Google Scholar] [DOI]
Irina Khripun,Sergey Vorobyev,Yanina Allahverdieva
Diabetes mellitus. 2020;
[Pubmed]  [Google Scholar] [DOI]
4 Metabolic Disorders and Male Hypogonadotropic Hypogonadism
Rosario Pivonello,Davide Menafra,Enrico Riccio,Francesco Garifalos,Marco Mazzella,Cristina de Angelis,Annamaria Colao
Frontiers in Endocrinology. 2019; 10
[Pubmed]  [Google Scholar] [DOI]
5 Vascular mechanisms of testosterone: the non-genomic point of view
Margarida Lorigo,Melissa Mariana,Manuel C. Lemos,Elisa Cairrao
The Journal of Steroid Biochemistry and Molecular Biology. 2019; : 105496
[Pubmed]  [Google Scholar] [DOI]
6 Vascular Pathways of Testosterone: Clinical Implications
Margarida Lorigo,Melissa Mariana,Nelson Oliveira,Manuel C. Lemos,Elisa Cairrao
Journal of Cardiovascular Translational Research. 2019;
[Pubmed]  [Google Scholar] [DOI]
7 Non-classical effects of sildenafil in clinical medicine: an interdisciplinary approach
I. A. Tyuzikov,A. V. Smirnov,L. V. Smirnova,I. V. Lesnikova
Medical Council. 2019; (21): 192
[Pubmed]  [Google Scholar] [DOI]
8 Sleep duration and risk of diabetes: Observational and Mendelian randomization studies
Jiao Wang,Man Ki Kwok,Shiu Lun Au Yeung,Albert Martin Li,Hugh Simon Lam,June Yue Yan Leung,Lai Ling Hui,Gabriel Matthew Leung,Catherine Mary Schooling
Preventive Medicine. 2019; 119: 24
[Pubmed]  [Google Scholar] [DOI]
9 Comparative study of testosterone and vitamin D analogue, elocalcitol, on insulin-controlled signal transduction pathway regulation in human skeletal muscle cells
C. Antinozzi,F. Marampon,P. Sgrò,V. Tombolini,A. Lenzi,C. Crescioli,L. Di Luigi
Journal of Endocrinological Investigation. 2019;
[Pubmed]  [Google Scholar] [DOI]
10 Male Obesity-related Secondary Hypogonadism – Pathophysiology, Clinical Implications and Management
Cornelius J Fernandez,Elias C Chacko,Joseph M Pappachan
European Endocrinology. 2019; 15(2): 83
[Pubmed]  [Google Scholar] [DOI]
11 Gender in Endocrine Diseases: Role of Sex Gonadal Hormones
R. Lauretta,M. Sansone,A. Sansone,F. Romanelli,M. Appetecchia
International Journal of Endocrinology. 2018; 2018: 1
[Pubmed]  [Google Scholar] [DOI]
12 Role of androgens in energy metabolism affecting on body composition, metabolic syndrome, type 2 diabetes, cardiovascular disease, and longevity: lessons from a meta-analysis and rodent studies
Naoki Harada
Bioscience, Biotechnology, and Biochemistry. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
13 Testosterone a key factor in gender related metabolic syndrome
V. E. Bianchi,V. Locatelli
Obesity Reviews. 2018;
[Pubmed]  [Google Scholar] [DOI]
14 Influence of testosterone substitution on glycemic control and endothelial markers in men with newly diagnosed functional hypogonadism and type 2 diabetes mellitus: a randomized controlled trial
Irina Khripun,Sergey Vorobyev,Igor Belousov,Michel Kogan,Michael Zitzmann
The Aging Male. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
15 Sexual Dysfunction and Hypogonadism in Men With Diabetes
Richard Bebb,Adam Millar,Gerald Brock
Canadian Journal of Diabetes. 2018; 42: S228
[Pubmed]  [Google Scholar] [DOI]
16 Long-term testosterone therapy in type 2 diabetes is associated with reduced mortality without improvement in conventional cardiovascular risk factors
Geoffrey Hackett,Nigel Cole,Akhilesh Mulay,Richard C. Strange,Sudarshan Ramachandran
BJU International. 2018;
[Pubmed]  [Google Scholar] [DOI]
17 Effectiveness of testosterone therapy in obese men with low testosterone levels, for losing weight, controlling obesity complications, and preventing cardiovascular events
Amanda S. Mangolim,Leonardo A. R. Brito,Vania S. Nunes-Nogueira
Medicine. 2018; 97(17): e0482
[Pubmed]  [Google Scholar] [DOI]
18 Impact of Metabolic Syndrome Factors on Testosterone and SHBG in Type 2 Diabetes Mellitus and Metabolic Syndrome
Mukhtar Mohammed,Molham AL-Habori,Ahmed Abdullateef,Riyadh Saif-Ali
Journal of Diabetes Research. 2018; 2018: 1
[Pubmed]  [Google Scholar] [DOI]
19 Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
Edgar D Torres Fernandez,Kristen V Adams,Maryam Syed,Rodrigo O Maranon,Damian G Romero,Licy L Yanes Cardozo
Journal of the Endocrine Society. 2018; 2(8): 949
[Pubmed]  [Google Scholar] [DOI]
20 Effects of testosterone supplement treatment in hypogonadal adult males with T2DM: a meta-analysis and systematic review
Jianzhong Zhang,Bin Yang,Wenhui Xiao,Xiao Li,Hongjun Li
World Journal of Urology. 2018;
[Pubmed]  [Google Scholar] [DOI]
21 Pubertal testis volume, age at pubertal onset, and adolescent blood pressure: Evidence from Hong Kongæs “Children of 1997” birth cohort
Man Ki Kwok,Gabriel M. Leung,C. Mary Schooling
American Journal of Human Biology. 2017; : e22993
[Pubmed]  [Google Scholar] [DOI]
22 Effects of testosterone supplementation therapy on lipid metabolism in hypogonadal men with T2DM: a meta-analysis of randomized controlled trials
K.-S. Zhang,M.-J. Zhao,Q. An,Y.-F. Jia,L.-L. Fu,J.-F. Xu,Y.-Q. Gu
Andrology. 2017;
[Pubmed]  [Google Scholar] [DOI]
23 Testosterone therapy improves well being and psychological health
Jason Akerman,Jason R. Kovac,Larry I. Lipshultz
Current Opinion in Urology. 2017; 27(6): 519
[Pubmed]  [Google Scholar] [DOI]
24 Cardiometabolic Features of Polycystic Ovary Syndrome: Role of Androgens
Licy L. Yanes Cardozo,Damian G. Romero,Jane F. Reckelhoff
Physiology. 2017; 32(5): 357
[Pubmed]  [Google Scholar] [DOI]
25 Guidelines for the Diagnosis and Treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus
Ivan I Dedov,Galina A Melænichenko,Marina V Shestakova,Roman V Rozhivanov,Anna L Terehova,Alexey V Zilov,Daria O Ladygina,Dmitriy G Kurbatov
Obesity and metabolism. 2017; 14(4): 83
[Pubmed]  [Google Scholar] [DOI]
26 Guidelines for the diagnosis and treatment of testosterone deficiency (hypogonadism) in male patients with diabetes mellitus (Draft)
Galina Afanasæevna Melnichenko,Marina Vladimirovna Shestakova,Roman Viktorovich Rozhivanov,Anna Leontæevna Terehova,Alexey Vadimovich Zilov,Daria Olegovna Ladygina,Dmitriy Gennadæevich Kurbatov
Diabetes mellitus. 2017; 20(2): 151
[Pubmed]  [Google Scholar] [DOI]
27 Sex and gender differences in therapy of type 2 diabetes
Alexandra Kautzky-Willer,Jürgen Harreiter
Diabetes Research and Clinical Practice. 2017;
[Pubmed]  [Google Scholar] [DOI]
28 Testosterone deficiency in the aging male
J. Abram McBride,Culley C. Carson,Robert M. Coward
Therapeutic Advances in Urology. 2016; 8(1): 47
[Pubmed]  [Google Scholar] [DOI]
29 In Search for a Common Pathway for Health Issues in Men - the Sign of a Holmesian Deduction
Fouad Aoun,Anthony Kallas Chemaly,Simone Albisinni,Marc Zanaty,Thierry Roumeguere
Asian Pacific Journal of Cancer Prevention. 2016; 17(1): 1
[Pubmed]  [Google Scholar] [DOI]
30 Interaction of sex steroid hormones and obesity on insulin resistance and type 2 diabetes in men: the Third National Health and Nutrition Examination Survey
Ji Li,Hong Lai,Shaoguang Chen,Hong Zhu,Shenghan Lai
Journal of Diabetes and its Complications. 2016;
[Pubmed]  [Google Scholar] [DOI]
31 Spironolactone and glucose metabolism, a systematic review and meta-analysis of randomized controlled trials
Jie V. Zhao,Lin Xu,Shi Lin Lin,C Mary Schooling
Journal of the American Society of Hypertension. 2016;
[Pubmed]  [Google Scholar] [DOI]
32 Glucose-6-Phosphate Dehydrogenase Deficiency and Physical and Mental Health until Adolescence
Man Ki Kwok,Gabriel M. Leung,C. Mary Schooling,Junwen Wang
PLOS ONE. 2016; 11(11): e0166192
[Pubmed]  [Google Scholar] [DOI]
33 Associations of Cardiovascular Risk Factors with Carotid Intima-Media Thickness in Middle-Age Adults and Elders
Tzu-Wei Wu,Chung-Lieh Hung,Chun-Chieh Liu,Yih-Jer Wu,Li-Yu Wang,Hung-I Yeh
Journal of Atherosclerosis and Thrombosis. 2016;
[Pubmed]  [Google Scholar] [DOI]
34 Testosterone and Cardiovascular Disease
Robert A. Kloner,Culley Carson,Adrian Dobs,Stephen Kopecky,Emile R. Mohler
Journal of the American College of Cardiology. 2016; 67(5): 545
[Pubmed]  [Google Scholar] [DOI]
35 Effects of continuous long-term testosterone therapy (TTh) on anthropometric, endocrine and metabolic parameters for up to 10 years in 115 hypogonadal elderly men: real-life experience from an observational registry study
A. A. Yassin,J. Nettleship,Y. Almehmadi,M. Salman,F. Saad
Andrologia. 2016; : n/a
[Pubmed]  [Google Scholar] [DOI]
36 THERAPY OF ENDOCRINE DISEASE: Testosterone supplementation and body composition: results from a meta-analysis study
Giovanni Corona,Vito A Giagulli,Elisa Maseroli,Linda Vignozzi,Antonio Aversa,Michael Zitzmann,Farid Saad,Edoardo Mannucci,Mario Maggi
European Journal of Endocrinology. 2016; 174(3): R99
[Pubmed]  [Google Scholar] [DOI]
37 Pharmacologic androgen deprivation and cardiovascular disease risk factors: a systematic review
Matthew L. Romo,Aileen M. McCrillis,Jennifer Brite,Dalicia Reales,Jennifer B. Dowd,C. Mary Schooling
European Journal of Clinical Investigation. 2015; 45(5): 475
[Pubmed]  [Google Scholar] [DOI]
38 Elderly men over 65 years of age with late-onset hypogonadism benefit as much from testosterone treatment as do younger men
Farid Saad,Aksam Yassin,Ahmad Haider,Gheorghe Doros,Louis Gooren
Korean Journal of Urology. 2015; 56(4): 310
[Pubmed]  [Google Scholar] [DOI]
39 Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence
Kitty Kit Ting Cheung,Andrea On Yan Luk,Wing Yee So,Ronald Ching Wan Ma,Alice Pik Shan Kong,Francis Chun Chung Chow,Juliana Chung Ngor Chan
Journal of Diabetes Investigation. 2015; 6(2): 112
[Pubmed]  [Google Scholar] [DOI]
40 Testosterone and obesity
D. M. Kelly,T. H. Jones
Obesity Reviews. 2015; 16(7): 581
[Pubmed]  [Google Scholar] [DOI]
41 Debate: Testosterone Therapy Reduces Cardiovascular Risk in Men with Diabetes. Against the Motion
C. Mary Schooling,Lin Xu,Jie Zhao
Current Cardiovascular Risk Reports. 2015; 9(5)
[Pubmed]  [Google Scholar] [DOI]
42 Effects of testosterone replacement on glucose and lipid metabolism
Isabel Errazuriz,Simmi Dube,Ananda Basu,Rita Basu
Cardiovascular Endocrinology. 2015; 4(3): 95
[Pubmed]  [Google Scholar] [DOI]
43 Contemporary perspective and management of testosterone deficiency: Modifiable factors and variable management
Shin-ichi Hisasue
International Journal of Urology. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
44 Prevalence, Pathophysiology, and Management of Androgen Deficiency in Men with Metabolic Syndrome, Type 2 Diabetes Mellitus, or Both
Shawn Riser Taylor,Lindsy M. Meadowcraft,Bobbie Williamson
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy. 2015; 35(8): 780
[Pubmed]  [Google Scholar] [DOI]
45 Effects of testosterone treatment on glucose metabolism and symptoms in men with type 2 diabetes and the metabolic syndrome: a systematic review and meta-analysis of randomized controlled clinical trials
Mathis Grossmann,Rudolf Hoermann,Gary Wittert,Bu B. Yeap
Clinical Endocrinology. 2015; 83(3): 344
[Pubmed]  [Google Scholar] [DOI]
46 Effects of intermission and resumption of long-term testosterone replacement therapy on body weight and metabolic parameters in hypogonadal in middle-aged and elderly men
Aksam Yassin,Yousef Almehmadi,Farid Saad,Gheorghe Doros,Louis Gooren
Clinical Endocrinology. 2015; : n/a
[Pubmed]  [Google Scholar] [DOI]
47 Adolescent testosterone, muscle mass and glucose metabolism: evidence from the ‘Children of 1997’ birth cohort in Hong Kong
W. W. Hou,M. A. Tse,T. H. Lam,G. M. Leung,C. M. Schooling
Diabetic Medicine. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
48 Testosterone supplementation and cardiovascular risk
Giovanni Corona,Mario Maggi
Trends in Cardiovascular Medicine. 2014;
[Pubmed]  [Google Scholar] [DOI]
49 Injectable testosterone undecanoate for the treatment of hypogonadism
Giovanni Corona,Elisa Maseroli,Mario Maggi
Expert Opinion on Pharmacotherapy. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
50 Marked Testosterone Deficiency-Related Symptoms May be Associated to Higher Metabolic Risk in Men with Low Testosterone Levels
Eduard García-Cruz,Asier Leibar-Tamayo,Javier Romero-Otero,Ignacio Asiaín,Albert Carrión,Roberto Castañeda,Laura Mateu,Pilar Luque,Oscar Cardeñosa,Antonio Alcaraz
The Journal of Sexual Medicine. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
51 Are We Testing Appropriately for Low Testosterone?: Characterization of Tested Men and Compliance with Current Guidelines
Rena D. Malik,Brittany Lapin,Chihsiung E. Wang,Justin C. Lakeman,Brian T. Helfand
The Journal of Sexual Medicine. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
52 Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysis
Giovanni Corona,Elisa Maseroli,Giulia Rastrelli,Andrea M Isidori,Alessandra Sforza,Edoardo Mannucci,Mario Maggi
Expert Opinion on Drug Safety. 2014; : 1
[Pubmed]  [Google Scholar] [DOI]
53 Testosterone and cardiovascular disease
C. Mary Schooling
Current Opinion in Endocrinology & Diabetes and Obesity. 2014; 21(3): 202
[Pubmed]  [Google Scholar] [DOI]


Read this article